Inventor · disambiguated record
Frank Xing Chen
Also filed as: CHEN FRANK · CHEN FRANK X · CHEN FRANK XING
22 granted patents·2 pending applications·105 citations·filing 1999–2021
94Inventor score
Top patents by PatentIndex Score
24 records- 0196US10106541B2Intermediates for preparing CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2017·Granted Oct 23, 2018·16 cites·5 claims
- 0296US9174989B2Process for making CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Nov 3, 2015·19 cites·11 claims
- 0395US9850246B2Process for making CGRP receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Dec 26, 2017·17 cites·3 claims
- 0488US7605275B2Exo- and diastereo- selective syntheses of himbacine analogsSCHERING CORP·Filed 2006·Granted Oct 20, 2009·12 cites·11 claims
- 0584US7723531B2Process for the preparation of 6,6-dimethyl-3-azabicyclo-[3.1.0]-hexane compounds and enantiomeric salts thereofSCHERING CORP·Filed 2006·Granted May 25, 2010·5 cites·32 claims
- 0682US6288233B1Enantioselective alkylation of tricyclic compoundsSCHERING CORP·Filed 2000·Granted Sep 11, 2001·10 cites·1 claims
- 0779US7528263B2Oxidation process for the preparation of N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-{N-[(tert-butylamino)carbonyl]-3-methyl-L-valyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide and related compoundsSCHERING CORP·Filed 2006·Granted May 5, 2009·6 cites·32 claims
- 0873US11161834B2Methods of manufacturing of niraparibTESARO INC·Filed 2018·Granted Nov 2, 2021·1 cites·7 claims
- 0971US9249144B2Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compoundsOPKO HEALTH INC·Filed 2013·Granted Feb 2, 2016·1 cites·7 claims
- 1068US6307048B1Enantioselective alkylation of tricyclic compoundsSCHERING CORP·Filed 1999·Granted Oct 23, 2001·11 cites·17 claims
- 1165US7989653B2Exo- and diastereo-selective syntheses of himbacine analogsSCHERING CORP·Filed 2009·Granted Aug 2, 2011·0 cites·21 claims
- 1264US11629137B2Methods of manufacturing of niraparibTESARO INC·Filed 2021·Granted Apr 18, 2023·0 cites·14 claims
- 1359US7049440B2Enantioselective processSCHERING CORP·Filed 2003·Granted May 23, 2006·1 cites·25 claims
- 1458US7582763B2Enantioselective processSCHERING CORP·Filed 2005·Granted Sep 1, 2009·0 cites·4 claims
- 1557US6372909B1Synthesis of intermediates useful in preparing tricyclic compoundsSCHERING CORP·Filed 1999·Granted Apr 16, 2002·6 cites·15 claims
- 1653US9822116B2Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compoundsOPKO HEALTH INC·Filed 2016·Granted Nov 21, 2017·0 cites·20 claims
- 1753US8618314B2Exo- and diastereo-selective synthesis of himbacine analogsWU GEORGE G·Filed 2012·Granted Dec 31, 2013·0 cites·4 claims
- 1852US7786306B2Process for resolving chiral piperidine alcohol and process for synthesis of pyrazolo[1,5-a] pyrimidine derivatives using sameSCHERING CORP·Filed 2007·Granted Aug 31, 2010·0 cites·39 claims
- 1950US8258319B2Exo- and diastereo- selective synthesis of himbacine analogsWU GEORGE G·Filed 2011·Granted Sep 4, 2012·0 cites·11 claims
- 2049US8198463B2Process for the preparation of 6,6-dimethyl-3-azabicyclo-[3.3.0]-hexane compounds and enantiomeric salts thereofWU GEORGE·Filed 2010·Granted Jun 12, 2012·0 cites·3 claims
- 2149US2011124867A1Process and intermediates for the Synthesis of heterocyclic Substituted Piperazines with CXCR3 Antagonist ActivitySCHERING CORP·Filed 2008·Application pending·0 cites
- 2248US2014058116A1Process for preparing inhibitors of the hepatitis c virusXIE JI·Filed 2012·Application pending·0 cites
- 2346US6495689B2Synthesis of intermediates useful in preparing tricyclic compoundsSCHERING CORP·Filed 2001·Granted Dec 17, 2002·0 cites·5 claims
- 2444US8076479B2Process and intermediates for the synthesis of (3-alkyl-5-piperidin-1-yl-3,3a-dihydro-pyrazolo[1,5-a]pyrimidin-7-yl)-amino derivatives and intermediatesCHEN FRANK XING·Filed 2007·Granted Dec 13, 2011·0 cites·41 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →